niacinamide has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izzedine, H | 1 |
| Mangier, M | 1 |
| Ory, V | 1 |
| Zhang, SY | 1 |
| Sendeyo, K | 1 |
| Bouachi, K | 1 |
| Audard, V | 1 |
| Péchoux, C | 1 |
| Soria, JC | 1 |
| Massard, C | 1 |
| Bahleda, R | 1 |
| Bourry, E | 1 |
| Khayat, D | 1 |
| Baumelou, A | 1 |
| Lang, P | 1 |
| Ollero, M | 1 |
| Pawlak, A | 1 |
| Sahali, D | 1 |
1 other study available for niacinamide and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Angiogenesis Inhibitors; Animals; Base Sequence; | 2014 |